M. Gaignage

发表

TLR7 activation by LDV / R848 (Resiquimod) prevents acute graft versus host disease and cooperates with anti-IL-27 antibody for optimal protection

M. Gaignage, 2018 .

Self-reactive CD4+ T cells activated during viral-induced demyelination do not prevent clinical recovery

S. Stohlman, C. Bergmann, M. Gaignage, 2015, Journal of Neuroinflammation.

Novel antibodies that selectively block mouse IL‐12 enable the re‐evaluation of the role of IL‐12 in immune protection and pathology

C. Uyttenhove, J. Van Snick, D. Vignali, 2021, European journal of immunology.

The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation

C. Uyttenhove, J. Van Snick, L. Dumoutier, 2018, Haematologica.

Involvement of Virus-Induced Interferon Production in IgG Autoantibody-Mediated Anemia

D. Su, S. Legrain, C. Breukel, 2021, International journal of molecular sciences.

Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN‐dependent inhibition of dendritic cells and allo‐responsive T cells

C. Uyttenhove, J. Van Snick, T. Michiels, 2017, Immunity, inflammation and disease.

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

P. Coulie, H. de Haard, H. Deckmyn, 2020, Nature Communications.

Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice

P. Coulie, L. Dumoutier, S. Lucas, 2022, Cancer Immunology, Immunotherapy.

Self-reactive CD4+ T cells activated during viral-induced demyelination do not prevent clinical recovery

S. Stohlman, C. Bergmann, M. Gaignage, 2015, Journal of Neuroinflammation.

Prophylactic treatment against GM‐CSF, but not IL‐17, abolishes relapses in a chronic murine model of multiple sclerosis

C. Uyttenhove, J. Van Snick, Zakia Nasr, 2018, European journal of immunology.